Peter Olupot-Olupot

Growth and puberty in African children with sickle cell anemia treated with hydroxyurea.Backeljauw, P. Tomlinson, G. Smart, L. R. Tshilolo, L. M. M. Williams, T. N. Santos, B. Olupot-Olupot, P. Stuber, S. E. Lane, A. Latham, T. S. Ware, R. E.
Blood Adv, (2026). :

Oral rehydration for severe malnutrition in children with moderate and severe dehydration (GASTROSAM): a phase 2, open-label, superiority randomised controlled trial.Maitland, K. Sainna, H. Connon, R. Ouattara, S. M. Sunyoto, T. Chara, A. Ogundipe, O. F. Maguina, A. S. Hamaluba, M. Olupot-Olupot, P. Alaroker, F. Okiror, W. Aromut, D. Mwajombo, E. Oguda, E. Mogaka, C. Langendorf, C. Dewez, J. E. Ciglenecki, I. Gibb, D. M. Petrucci, R. Coldiron, M. E. George, E. C. Gastrosam trial group
Lancet Child Adolesc Health, (2026). 10:319-329

Nasopharyngeal Microbiome Composition and its Clinical Correlates in Children Hospitalized with Severe Pneumonia in East Africa.Makori, T. O. Gicheru, E. T. Mburu, M. W. Sada, M. S. Nyawa, O. Mutunga, M. Lewa, C. Cheruiyot, R. Kiguli, S. Olupot-Olupot, P. Muhindo, R. Mogaka, C. Williams, T. N. Agoti, C. N. Maitland, K. Sande, C. J.
J Infect Dis, (2026). :

Gut microbial diversity impacts carbohydrate fermentation by children with severe acute malnutrition.Bisht, A. Ahn-Jarvis, J. Corbin, K. Harris, S. Troncoso-Rey, P. Olupot-Olupot, P. Calder, N. Walsh, K. Maitland, K. Frost, G. Warren, F. J.
iScience, (2026). 29:114640

A cost-consequence analysis of the children's administration oxygenation strategies trial (COAST) in severe pneumonia.Carroll, O. U. Grieve, R. Kiguli, S. Olupot-Olupot, P. Opoka, R. O. Alaroker, F. Tagoola, A. Hamaluba, M. Nabawanuka, E. Nalwanga, D. Williams, T. N. Thomas, K. Harrison, D. A. Mouncey, P. Giallongo, E. Rowan, K. Maitland, K. Sadique, Z.
PLOS Glob Public Health, (2026). 6:e0005654

Hydroxyurea pharmacokinetics in children with sickle cell anemia across different global populations.Power-Hays, A. McElhinney, K. E. Williams, T. N. Mochamah, G. Olupot-Olupot, P. Paasi, G. Reid, M. E. Rankine-Mullings, A. E. Opoka, R. O. John, C. C. McGann, P. T. Quinn, C. T. Punt, N. C. Smart, L. R. Stuber, S. E. Latham, T. S. Vinks, A. A. Ware, R. E.
Blood Adv, (2026). 10:418-427

Plasma folate dynamics in Plasmodium falciparum-infected African children treated with artemisinin combination therapy and single low-dose primaquine or placebo.Ajayi, S. Onyamboko, M. A. Olupot-Olupot, P. Ayuen, D. S. Chimjinda, N. Taya, C. Williams, T. N. Uyoga, S. Maitland, K. Fanello, C. Day, N. P. J. Mukaka, M. Taylor, W. R. J.
Malar J, (2025). 24:342

Epidemiological dynamics of influenza B virus across multiple seasons in Kenya and Uganda inferred from sequence data, 2010-2021.Nyarango, B. K. Owuor, D. C. Isoe, E. Mutunga, M. Cheruiyot, R. Katama, E. N. Makori, T. Lambisia, A. Nyiro, J. Githinji, G. Kiguli, S. Olupot-Olupot, P. Maitland, K. Agoti, C. N.
BMC Infect Dis, (2025). 25:1080

Single low dose primaquine to block the transmission of Plasmodium falciparum-proposed stand-alone and ACT-adapted regimens.Taylor, W. R. J. Olupot-Olupot, P. Onyamboko, M. A. Chimjinda, N. Taya, C. Pouplin, J. N. N. Williams, T. N. Maitland, K. Fanello, C. A. Day, N. P. J. Tarning, J. White, N. J. Mukaka, M.
BMC Med, (2025). 23:397

Early weaning from oxygen therapy in African children with severe pneumonia.Maitland, K. Giallongo, E. Hamaluba, M. Alaroker, F. Opoka, R. O. Tagoola, A. Nalwanga, D. Nabawanuka, E. Okiror, W. Nakuya, M. Aromut, D. Williams, T. N. Thomas, K. Harrison, D. A. Mouncey, P. Bush, A. Fraser, J. F. Rowan, K. Olupot-Olupot, P. Kiguli, S. Coast trial group
BMC Med, (2025). 23:366

Intravenous Rehydration for Severe Acute Malnutrition with Gastroenteritis.Maitland, K. Ouattara, S. M. Sainna, H. Chara, A. Ogundipe, O. F. Sunyoto, T. Hamaluba, M. Olupot-Olupot, P. Alaroker, F. Connon, R. Saidou Maguina, A. Okiror, W. Amorut, D. Mwajombo, E. Oguda, E. Mogaka, C. Langendorf, C. Dewez, J. E. Ciglenecki, I. Gibb, D. M. Coldiron, M. E. Petrucci, R. George, E. C. Gastrosam Trial Group
N Engl J Med, (2025). 393:1257-1268

Comparing HemoCue(R) and Quantitative Buffy Coat(R) and Coulter Counter-measured haemoglobin concentrations in African children with acute uncomplicated malaria: a Bland-Altman analysis.Ayuen, D. S. Olupot-Olupot, P. Muhindo, R. Onyamboko, M. A. Ajayi, S. Chimjinda, N. Taya, C. Uyoga, S. Williams, T. N. Maitland, K. Fanello, C. Day, N. P. J. Taylor, W. R. Mukaka, M.
Malar J, (2025). 24:77

Catastrophic expenditure associated with childhood hospitalisation for acute illness in Kenya and Uganda: a cross-sectional study.Jemutai, J. Njuguna, R. G. Laurence, Y. V. Murunga, S. Ogwang, C. Mwaringa, S. Mwalekwa, L. Timbwa, M. Paasi, G. Olupot-Olupot, P. Juma, M. Thitiri, J. Ngao, N. Singa, B. Mukisa, J. Mupere, E. Lancioni, C. Sukhtankar, P. Tickell, K. D. Fakhar Uddin, M. Molyneux, S. Walson, J. L. Vassall, A. Berkley, J.
BMJ Public Health, (2025). 3:e001173

Effect of nutritional supplementation with lipid-based therapeutic food on body composition of non-severely malnourished African children aged 6-59 months hospitalized with severe pneumonia.Nalwanga, D. Musiime, V. Kiguli, S. Olupot-Olupot, P. Alaroker, F. Opoka, R. Tagoola, A. Mnjala, H. Mogaka, C. Nabawanuka, E. Giallongo, E. Karamagi, C. Briend, A. Maitland, K.
J Trop Pediatr, (2025). 71:

Azithromycin in severe malaria bacterial co-infection in African children (TABS-PKPD): a phase II randomised controlled trial.Connon, R. Olupot-Olupot, P. Pistorius, A. M. A. Okiror, W. Ssenyondo, T. Muhindo, R. Uyoga, S. Mpoya, A. Williams, T. N. Gibb, D. M. Walker, A. S. Ter Heine, R. George, E. C. Maitland, K.
BMC Med, (2024). 22:516

Is fat mass a better predictor of 6-month survival than muscle mass among African children aged 6-59 months with severe pneumonia?.Nalwanga, D. Musiime, V. Kiguli, S. Olupot-Olupot, P. Alaroker, F. Opoka, R. Tagoola, A. Mnjalla, H. Mogaka, C. Nabawanuka, E. Giallongo, E. Karamagi, C. Briend, A. Maitland, K.
BMC Nutr, (2024). 10:130

Legume-supplemented feed for children hospitalised with severe malnutrition: a phase II trial.Walsh, K. Kiosa, A. Olupot-Olupot, P. Alaroker, F. Okiror, W. Nakuya, M. Tssenyondo, T. Aromut, D. Okalebo, B. C. Muhindo, R. Mpoya, A. George, E. C. Frost, G. S. Maitland, K.
Br J Nutr, (2024). 132:372-381

Nutritional supplementation in children with severe pneumonia in Uganda and Kenya (COAST-Nutrition): a phase 2 randomised controlled trial.Kiguli, S. Olupot-Olupot, P. Hamaluba, M. Giallongo, E. Thomas, K. Alaroker, F. Opoka, R. O. Tagoola, A. Oyella, S. Nalwanga, D. Nabawanuka, E. Okiror, W. Nakuya, M. Amorut, D. Muhindo, R. Ayub, Mpoya Mnjalla, H. Oguda, E. Williams, T. N. Harrison, D. A. Rowan, K. Briend, A. Maitland, K.
EClinicalMedicine, (2024). 72:102640

Hydroxyurea dose optimisation for children with sickle cell anaemia in sub-Saharan Africa (REACH): extended follow-up of a multicentre, open-label, phase 1/2 trial.Aygun, B. Lane, A. Smart, L. R. Santos, B. Tshilolo, L. Williams, T. N. Olupot-Olupot, P. Stuber, S. E. Tomlinson, G. Latham, T. Ware, R. E. Reach Investigators
Lancet Haematol, (2024). 11:e425-e435

Reducing transfusion utilization for children with sickle cell anemia in sub-Saharan Africa with hydroxyurea: Analysis from the phase I/II REACH trial.Power-Hays, A. Tomlinson, G. A. Tshilolo, L. Santos, B. Williams, T. N. Olupot-Olupot, P. Smart, L. R. Aygun, B. Lane, A. Stuber, S. E. Latham, T. Ware, R. E.
Am J Hematol, (2024). 99:625-632